Trials / Not Yet Recruiting
Not Yet RecruitingNCT06626932
Implications of Biological and Procedural Factors of 18-f FDG Uptake by Normal Organs and Neoplastic Lesions
Implications of Biological and Procedural Factors of 18-f FDG PET/CT Uptake by Normal Organs and Neoplastic Lesions
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 259 (estimated)
- Sponsor
- mahenoor alaa eldeen naem · Academic / Other
- Sex
- All
- Age
- 1 Year – 90 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate implications of biological and procedural factors of 18-f FDG PET/CT uptake on normal organs and neoplastic lesions.
Detailed description
18-f FDG is used on oncological patients undergoing PET/CT study at our nuclear medicine unit , its uptake by the tissues depends on glucose blood level and consumption then we evaluate the implications of biological and procedural factors on the uptake by normal organs and neoplastic lesions using standardized uptake values SUVmax , mean and peak.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | 18 FDG (Fludeoxyglucose 18F) | 18-f FDG |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2026-10-01
- Completion
- 2026-11-01
- First posted
- 2024-10-04
- Last updated
- 2024-10-04
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06626932. Inclusion in this directory is not an endorsement.